Showing 1 - 10 of 13,219
Persistent link: https://www.econbiz.de/10011695731
While most countries have harmonized intellectual property rights (IPR) legislation, the dispute about the optimal level of IPR-enforcement remains. This paper develops an endogenous growth framework with two open economies satisfying the classical North-South assumptions to study (a)...
Persistent link: https://www.econbiz.de/10011753214
exclusivity for pharmaceuticals products and evaluates safeguards against such evergreening. …
Persistent link: https://www.econbiz.de/10011773251
This paper explores the use of a micro-economic model to analyse the provisions and parties of bioprospecting contracts. It focuses on the pharmaceutical industry as the representative biodiversity buyer, presenting an original theoretical framework that explains the main contract...
Persistent link: https://www.econbiz.de/10010312374
Persistent link: https://www.econbiz.de/10014374380
Persistent link: https://www.econbiz.de/10014374515
This paper elaborates on the recent race to sequence the human genome. Starting from the debate on public vs. private research arising from the genome case, the paper shows that in some fundamental research areas, where knowledge externalities play an important role, market and non-market...
Persistent link: https://www.econbiz.de/10011608822
This paper studies the interaction between two dynamic domains, (1) an evolutionary biological system ('the environment') whose behaviour determines the availability of a resource stock, and (2) an industry where access to the resource stock is determined by the outcome of a patent race. The...
Persistent link: https://www.econbiz.de/10011335747
If redistribution is distortionary, and if the income of skilled workers is due to knowledgeintensive activities and depends positively on intellectual property, a social planner which cares about income distribution may in principle want to use a reduction in Intellectual Property Rights (IPRs)...
Persistent link: https://www.econbiz.de/10010262329